PAUSE Seminar: Anaerobic Antibiotics, the Gut Microbiome and CAR T Outcomes
Bioinformatics Bioinformatics-1131, 130 Mason Farm Rd, Chapel Hill, NC, United StatesTessa Andermann, PhD, Assistant Professor of Medicine, studies infectious diseases of immunocompromised patients. Dr. Andermann’s research focus on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations.